Phase 2 – Pharmaceuticals

Phase II of BioStem Technologies business plan is currently underway. Qualified Pharma Ingredients, the Companies pharmaceutical ingredient supply business established all necessary licensing and is now developing a sales force along with its strategic business partnerships. The executive team will soon be moving into its state-of-the-art laboratory facility to begin development of contract formulation work to include filing of NDA and ANDA drug applications. Blue Tech Ind., a wholly owned subsidiary of BioStem Technologies, currently has pre-clinical trials being performed at University of Miami.